Cargando…

Puerarin-V Improve Mitochondrial Respiration and Cardiac Function in a Rat Model of Diabetic Cardiomyopathy via Inhibiting Pyroptosis Pathway through P2X7 Receptors

There is a new form of puerarin, puerarin-V, that has recently been developed, and it is unclear whether puerarin-V has a cardioprotective effect on diabetic cardiomyopathy (DCM). Here, we determined whether puerarin-V had any beneficial influence on the pathophysiology of DCM and explored its possi...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Shuchan, Dawuti, Awaguli, Gong, Difei, Wang, Ranran, Yuan, Tianyi, Wang, Shoubao, Xing, Cheng, Lu, Yang, Du, Guanhua, Fang, Lianghua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9653882/
https://www.ncbi.nlm.nih.gov/pubmed/36361807
http://dx.doi.org/10.3390/ijms232113015
_version_ 1784828791043915776
author Sun, Shuchan
Dawuti, Awaguli
Gong, Difei
Wang, Ranran
Yuan, Tianyi
Wang, Shoubao
Xing, Cheng
Lu, Yang
Du, Guanhua
Fang, Lianghua
author_facet Sun, Shuchan
Dawuti, Awaguli
Gong, Difei
Wang, Ranran
Yuan, Tianyi
Wang, Shoubao
Xing, Cheng
Lu, Yang
Du, Guanhua
Fang, Lianghua
author_sort Sun, Shuchan
collection PubMed
description There is a new form of puerarin, puerarin-V, that has recently been developed, and it is unclear whether puerarin-V has a cardioprotective effect on diabetic cardiomyopathy (DCM). Here, we determined whether puerarin-V had any beneficial influence on the pathophysiology of DCM and explored its possible mechanisms. By injecting 30 mg/kg of STZ intraperitoneally, diabetes was induced in rats. After a week of stability, the rats were injected subcutaneously with ISO (5 mg/kg). We randomly assigned the rats to eight groups: (1) control; (2) model; (3) metformin; (4–6) puerarin-V at different doses; (7) puerarin (API); (8) puerarin injection. DCM rats were found to have severe cardiac insufficiency (arrythmia, decreased LVdP/dt, and increased E/A ratio). In addition, cardiac injury biomarkers (cTn-T, NT-proBNP, AST, LDH, and CK-MB), inflammatory cytokines (IL-1β, IL-18, IL-6, and TNF-α), and oxidative damage markers (MDA, SOD and GSH) were markedly increased. Treatment with puerarin-V positively adjusts these parameters mentioned above by improving cardiac function and mitochondrial respiration, suppressing myocardial inflammation, and maintaining the structural integrity of the cardiac muscle. Moreover, treatment with puerarin-V inhibits the P2X7 receptor-mediated pyroptosis pathway that was upregulated in diabetic hearts. Given these results, the current study lends credence to the idea that puerarin-V can reduce myocardial damage in DCM rats. Furthermore, it was found that the effect of puerarin-V in diabetic cardiomyopathy is better than the API, the puerarin injection, and metformin. Collectively, our research provides a new therapeutic option for the treatment of DCM in clinic.
format Online
Article
Text
id pubmed-9653882
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-96538822022-11-15 Puerarin-V Improve Mitochondrial Respiration and Cardiac Function in a Rat Model of Diabetic Cardiomyopathy via Inhibiting Pyroptosis Pathway through P2X7 Receptors Sun, Shuchan Dawuti, Awaguli Gong, Difei Wang, Ranran Yuan, Tianyi Wang, Shoubao Xing, Cheng Lu, Yang Du, Guanhua Fang, Lianghua Int J Mol Sci Article There is a new form of puerarin, puerarin-V, that has recently been developed, and it is unclear whether puerarin-V has a cardioprotective effect on diabetic cardiomyopathy (DCM). Here, we determined whether puerarin-V had any beneficial influence on the pathophysiology of DCM and explored its possible mechanisms. By injecting 30 mg/kg of STZ intraperitoneally, diabetes was induced in rats. After a week of stability, the rats were injected subcutaneously with ISO (5 mg/kg). We randomly assigned the rats to eight groups: (1) control; (2) model; (3) metformin; (4–6) puerarin-V at different doses; (7) puerarin (API); (8) puerarin injection. DCM rats were found to have severe cardiac insufficiency (arrythmia, decreased LVdP/dt, and increased E/A ratio). In addition, cardiac injury biomarkers (cTn-T, NT-proBNP, AST, LDH, and CK-MB), inflammatory cytokines (IL-1β, IL-18, IL-6, and TNF-α), and oxidative damage markers (MDA, SOD and GSH) were markedly increased. Treatment with puerarin-V positively adjusts these parameters mentioned above by improving cardiac function and mitochondrial respiration, suppressing myocardial inflammation, and maintaining the structural integrity of the cardiac muscle. Moreover, treatment with puerarin-V inhibits the P2X7 receptor-mediated pyroptosis pathway that was upregulated in diabetic hearts. Given these results, the current study lends credence to the idea that puerarin-V can reduce myocardial damage in DCM rats. Furthermore, it was found that the effect of puerarin-V in diabetic cardiomyopathy is better than the API, the puerarin injection, and metformin. Collectively, our research provides a new therapeutic option for the treatment of DCM in clinic. MDPI 2022-10-27 /pmc/articles/PMC9653882/ /pubmed/36361807 http://dx.doi.org/10.3390/ijms232113015 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Sun, Shuchan
Dawuti, Awaguli
Gong, Difei
Wang, Ranran
Yuan, Tianyi
Wang, Shoubao
Xing, Cheng
Lu, Yang
Du, Guanhua
Fang, Lianghua
Puerarin-V Improve Mitochondrial Respiration and Cardiac Function in a Rat Model of Diabetic Cardiomyopathy via Inhibiting Pyroptosis Pathway through P2X7 Receptors
title Puerarin-V Improve Mitochondrial Respiration and Cardiac Function in a Rat Model of Diabetic Cardiomyopathy via Inhibiting Pyroptosis Pathway through P2X7 Receptors
title_full Puerarin-V Improve Mitochondrial Respiration and Cardiac Function in a Rat Model of Diabetic Cardiomyopathy via Inhibiting Pyroptosis Pathway through P2X7 Receptors
title_fullStr Puerarin-V Improve Mitochondrial Respiration and Cardiac Function in a Rat Model of Diabetic Cardiomyopathy via Inhibiting Pyroptosis Pathway through P2X7 Receptors
title_full_unstemmed Puerarin-V Improve Mitochondrial Respiration and Cardiac Function in a Rat Model of Diabetic Cardiomyopathy via Inhibiting Pyroptosis Pathway through P2X7 Receptors
title_short Puerarin-V Improve Mitochondrial Respiration and Cardiac Function in a Rat Model of Diabetic Cardiomyopathy via Inhibiting Pyroptosis Pathway through P2X7 Receptors
title_sort puerarin-v improve mitochondrial respiration and cardiac function in a rat model of diabetic cardiomyopathy via inhibiting pyroptosis pathway through p2x7 receptors
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9653882/
https://www.ncbi.nlm.nih.gov/pubmed/36361807
http://dx.doi.org/10.3390/ijms232113015
work_keys_str_mv AT sunshuchan puerarinvimprovemitochondrialrespirationandcardiacfunctioninaratmodelofdiabeticcardiomyopathyviainhibitingpyroptosispathwaythroughp2x7receptors
AT dawutiawaguli puerarinvimprovemitochondrialrespirationandcardiacfunctioninaratmodelofdiabeticcardiomyopathyviainhibitingpyroptosispathwaythroughp2x7receptors
AT gongdifei puerarinvimprovemitochondrialrespirationandcardiacfunctioninaratmodelofdiabeticcardiomyopathyviainhibitingpyroptosispathwaythroughp2x7receptors
AT wangranran puerarinvimprovemitochondrialrespirationandcardiacfunctioninaratmodelofdiabeticcardiomyopathyviainhibitingpyroptosispathwaythroughp2x7receptors
AT yuantianyi puerarinvimprovemitochondrialrespirationandcardiacfunctioninaratmodelofdiabeticcardiomyopathyviainhibitingpyroptosispathwaythroughp2x7receptors
AT wangshoubao puerarinvimprovemitochondrialrespirationandcardiacfunctioninaratmodelofdiabeticcardiomyopathyviainhibitingpyroptosispathwaythroughp2x7receptors
AT xingcheng puerarinvimprovemitochondrialrespirationandcardiacfunctioninaratmodelofdiabeticcardiomyopathyviainhibitingpyroptosispathwaythroughp2x7receptors
AT luyang puerarinvimprovemitochondrialrespirationandcardiacfunctioninaratmodelofdiabeticcardiomyopathyviainhibitingpyroptosispathwaythroughp2x7receptors
AT duguanhua puerarinvimprovemitochondrialrespirationandcardiacfunctioninaratmodelofdiabeticcardiomyopathyviainhibitingpyroptosispathwaythroughp2x7receptors
AT fanglianghua puerarinvimprovemitochondrialrespirationandcardiacfunctioninaratmodelofdiabeticcardiomyopathyviainhibitingpyroptosispathwaythroughp2x7receptors